본문 바로가기
KERD
논문KCI 등재

방풍통성산의 지방대사조절을 통한 비알콜성 지방간 유도 인슐린저항성 개선 효과

The Effect of Bangpungtongsungsan on Insulin Resistance Induced by Non-alcoholic Fatty Liver Disease (NAFLD)

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives Bangpungtongsungsan is an herbal medicine that treats obesity and dampness-phlegm. The aim of this study was to investigate the efficacy of Bangpungtongsungsan on insulin resistance induced by non-alcoholic fatty liver disease. Methods Male 6-week-old C57BL/6 male mice were divided into four groups: control group (Ctrl), high fat diet group (HFF), high fat diet with Bangpungtongsungsan extract administration group (BT1), and high fat diet with double concentration of Bangpungtongsungsan extract administration group (BT2). Each 10 mice were allocated to each group (total of 40 mice). All mice were allowed to eat fat rich diet freely throughout the experiment. To examine the effect of Bangpungtongsungsan, we observed weight changes, lipid blot distributions, PGC-1, p-IκB, 8-OHdG, p-JNK, total cholesterol and glucose levels. Results Comparing of body weight measurements between 4 groups, weight gain was significantly lower in BT1 and BT2 group than the HFF group. The distribution of lipid blots and positive reaction of PGC-1 were significantly lower in BT1 and BT2 group. The positive reaction of p-IκB and 8-OHdG in hepatic tissues was significantly lower in BT1 and BT2 group. The positive reaction of p-JNK in hepatic tissues was significantly lower in BT1 and BT2 group. Total cholesterol and glucose levels were significantly lower in BT1 and BT2 group. Conclusions Bangpungtongsungsan has the effect of improving non-alcoholic fatty liver induced insulin resistance through regulation of lipid metabolism.

Abstract

Objectives Bangpungtongsungsan is an herbal medicine that treats obesity and dampness-phlegm. The aim of this study was to investigate the efficacy of Bangpungtongsungsan on insulin resistance induced by non-alcoholic fatty liver disease. Methods Male 6-week-old C57BL/6 male mice were divided into four groups: control group (Ctrl), high fat diet group (HFF), high fat diet with Bangpungtongsungsan extract administration group (BT1), and high fat diet with double concentration of Bangpungtongsungsan extract administration group (BT2). Each 10 mice were allocated to each group (total of 40 mice). All mice were allowed to eat fat rich diet freely throughout the experiment. To examine the effect of Bangpungtongsungsan, we observed weight changes, lipid blot distributions, PGC-1, p-IκB, 8-OHdG, p-JNK, total cholesterol and glucose levels. Results Comparing of body weight measurements between 4 groups, weight gain was significantly lower in BT1 and BT2 group than the HFF group. The distribution of lipid blots and positive reaction of PGC-1 were significantly lower in BT1 and BT2 group. The positive reaction of p-IκB and 8-OHdG in hepatic tissues was significantly lower in BT1 and BT2 group. The positive reaction of p-JNK in hepatic tissues was significantly lower in BT1 and BT2 group. Total cholesterol and glucose levels were significantly lower in BT1 and BT2 group. Conclusions Bangpungtongsungsan has the effect of improving non-alcoholic fatty liver induced insulin resistance through regulation of lipid metabolism.

참고문헌 (45)

  1. Clark JM, "The epidemiology of nonalcoholic fatty liver disease in adults", J Clin Gastroenterol, 40(Suppl 1), pp.S5~S10 (2006)
  2. "The press release"[URL]
  3. 오경원, "한국 소아청소년의 비만 유병률 추이: 1997년과 2005년 비교", Clinical and Experimental Pediatrics, 51(9), pp.950~955 (2008), 대한소아청소년과학회
  4. Bellentani S, "Epidemiology of non-alcoholic fatty liver disease", Dig Dis, 28(1), pp.155~161 (2010)
  5. Barshop NJ, "Review article : epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease", Aliment Pharmacol Ther, 28(1), pp.13~24 (2008)
  6. Powell EE, "The natural history of nonalcoholic steatohepatitis : a follow-up study of forty-two patients for up to 21 years", Hepatology, 11(1), pp.74~80 (1990)
  7. 안예지, "고지방식이 C57BL", 6N 모델에서 降脂丸의 농도별 비알콜성 지방간질환 개선효과, 2014, pp.29(2), 47~54[DOI]
  8. Lee BW, "Management of patients with nonalcoholic fatty liver disease with lifestyle modification", Korean Diabetes, 19, pp.82~87 (2018)
  9. Cone CJ, "Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease", Ann Pharmacother, 44(10), pp.1655~1659 (2010)
  10. Péterfy M, "Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin", Nat Genet, 27(1), pp.121~124 (2001)
  11. Xu J, "Lipin deficiency impairs diurnal metabolic fuel switching", Diabetes, 55(12), pp.3429~3438 (2006)
  12. Yao-Borengasser A, "Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation", Diabetes, 55(10), pp.2811~2818 (2006)
  13. 홍지영, "방풍통성산 및 홍국이 고지방식이로 유발된 비만 생쥐의 체중, 혈청과 지방세포내 β3AR 변화에 미치는 영향", 박사, 제3의학, pp.2010
  14. Choi EM, "Effects of Fangfengtongsheng-san on obese patients", J Soc Korean Med Obes Res, 1(1), pp.57~62 (2001)
  15. Ahn JM, "Effects of Bangpoongtongsungsan on the weight and lipid metabolism of induced obesity rats", J Kyung Hee Univ Med Cent, 9(1), pp.69~82 (1993)
  16. 황상준, "防風通聖散이 高脂肪飼料 食餌로 誘發된 肥滿생쥐에서 肥滿遺傳子 및 關聯因子에 미치는 影響", 대한한의학회지, 27(1), pp.11~22 (2006), 대한한의학회
  17. Shin BC, "Effects of Bangpungtongseoungsan on rats with adipocyte induced by gold thioglucose", J Korean Med Rehabil, 7(1), pp.101~119 (1997)
  18. Akbar DH, "Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic : prevalence and general characteristics", Diabetes Care, 26(12), pp.3351~3352 (2003)
  19. 장영숙, "적소두가 비알코올성 지방간 질환 세포 모델에 미치는 효과", 동의생리병리학회지, 27(6), pp.802~809 (2013), 한의병리학회
  20. 김소연, "비알코올성 지방간 세포 모델에서 곤포의 효능과 기전 연구", 대한한방내과학회지, 35(2), pp.175~183 (2014), 대한한방내과학회
  21. 한창우, "Palmitate로 유발된 비알코올성 지방간 모델에 대한 KH淸肝湯의 효과 연구", 대한한의학회지, 32(1), pp.109~120 (2011), 대한한의학회
  22. 김기태, "AHP 기법을 이용한 비알콜성 지방간에 茵蔯蒿湯 선택과정 분석", 대한한의진단학회지, 19(3), pp.159~171 (2015), 대한한의진단학회
  23. 정양삼, "고지방식이 비만마우스 모델에서 파키스탄산 및 중국산 마황으로 조성된 降脂丸-1,2,3,4과 降脂丸-1+加味消滯丸의 비알콜성 지방간질환 개선효과 비교", 대한본초학회지, 29(6), pp.149~156 (2014), 대한본초학회
  24. Browning JD, "Prevalence of hepatic steatosis in an urban population in the United States : impact of ethnicity", Hepatology, 40(6), pp.1387~1395 (2004)
  25. Day CP, "Natural history of NAFLD : remarkably benign in the absence of cirrhosis", Gastroenterology, 129(1), pp.375~378 (2005)
  26. Ekstedt M, "Long-term follow-up of patients with NAFLD and elevated liver enzymes", Hepatology, 44(4), pp.865~873 (2006)
  27. Fassio E, "Natural history of nonalcoholic steatohepatitis : a longitudinal study of repeat liver biopsies", Hepatology, 40(4), pp.820~826 (2004)
  28. Adams LA, "The natural history of nonalcoholic fatty liver disease : a population-based cohort study", Gastroenterology, 129(1), pp.113~121 (2005)
  29. Son CK, "The research of immunological function in liver", J Korean Orient Med, 22(1), pp.3~9 (2001)
  30. 이상민, "추출방식에 따른 防風通聖散이 지방세포 대사에 미치는 영향", Journal of Pharmacopuncture, 11(1), pp.163~176 (2008), 대한약침학회
  31. 정승희, "비만유도 흰쥐에 대한 방풍통성산가미방 (防風通聖散加味方)의항고지혈 효과 및 항산화 효과", 생약학회지, 37(3), pp.190~195 (2006), 한국생약학회
  32. 이장천, "加味防風通聖散이 고지방식이 급여 흰쥐의 체지질구성과 항산화능에 미치는 영향", 대한본초학회지, 20(2), pp.69~75 (2005), 대한본초학회
  33. Lee NH, "Effect of Bangpoorgtonsungsan on the hypertention and hyperlipidemia", J Kyung Hee Univ Med Cent, 22(1), pp.101~109 (1991)
  34. Yun KY, "Donguiimsangbangjehag", pp.52~54 (1992), Myungbo Publishing Co
  35. Hwang DY, "Bangyakhappyeon", pp.122~ (1987), Namsandang
  36. Park MJ, "Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1αregulation in vitro and in vivo", J Hepatol, 61(5), pp.1151~1157 (2014)
  37. Yamaguchi K, "Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis", Hepatology, 45(6), pp.1366~1374 (2007)
  38. Feldstein AE, "Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway", Hepatology, 40(1), pp.185~194 (2004)
  39. Jou J, "Mechanisms of disease progression in nonalcoholic fatty liver disease", Semin Liver Dis, 28(4), pp.370~379 (2008)
  40. Kim TH, "Obesity and fatty liver disease", Korean J Med, 68(4), pp.347~350 (2005)
  41. Baeuerle PA, "NF-κB: ten years after", Cell, 87(1), pp.13~20 (1996)
  42. Jung YJ, "IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB", COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis, 2003, pp.17(14), 2115~2117
  43. Cha HY, "Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC", Nga mice under high-fat diet conditions, 2016, pp.2016, 1~13
  44. Lipscombe LL, "Thiazolidinediones and cardiovascular outcomes in older patients with diabetes", JAMA, 298(22), pp.2634~2643 (2007)
  45. Lincoff AM, "Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus : a meta-analysis of randomized trials", JAMA, 298(10), pp.1180~1188 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (11건)